3rd Quarter - Report

MEDSECUREAN.COM for LUPIN PHARMACEUTICALS

Period 3rd Quarter 2025 Filed Sep 22, 2025 Signed by Kathleen D Jaeger

Official filing
Firm
MEDSECUREAN.COM
Client
LUPIN PHARMACEUTICALS
Income
$14,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Generic Industry Sustainability and tariifs broadly.

Foreign entity interest: Lupin Inc. owns Lupin Pharmaceuticals

LobbyistCovered position, as disclosed
KATHLEEN JAEGER New —

Contacted: SENATE; White House Office; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Commerce, Dept of (DOC)

Trade (domestic/foreign) TRD

Tarrifs - generic medicine

Foreign entity interest: Lupin Pharmaceuticals is owned by Lupin, Inc.

LobbyistCovered position, as disclosed
KATHLEEN JAEGER —

Contacted: White House Office; Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.